non hodgkin's lymphoma

Showing 1 - 25 of 27

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Hodgkin's Lymphoma Trial in Beijing (Allogenic CD19-CAR-?dT cell, Fludarabine, Cyclophosphamide)

Recruiting
  • Non Hodgkin's Lymphoma
  • Allogenic CD19-CAR-γδT cell
  • +2 more
  • Beijing, China
    Biotherapeutic Department, Chinese PLA General Hospital
Sep 22, 2022

Non Hodgkin's Lymphoma Trial in China (Chidamide, Fludarabine and cyclophosphamide, Anti-CD19 CAR-T cells)

Recruiting
  • Non Hodgkin's Lymphoma
  • Beijing, Beijing, China
  • +12 more
Jun 9, 2022

Non Hodgkin's Lymphoma Trial in Sacramento, Santa Rosa (Rituximab, Lenalidomide)

Active, not recruiting
  • Non Hodgkin's Lymphoma
  • Sacramento, California
  • +1 more
Nov 15, 2021

Non Hodgkin's Lymphoma, NHL, Aggressive NHL Trial in United States (Veltuzumab and 90Y-Epratuzumab Tetraxetan, 90Y-epratuzumab

Withdrawn
  • Non Hodgkin's Lymphoma
  • +3 more
  • Veltuzumab and 90Y-Epratuzumab Tetraxetan
  • +2 more
  • Newark, Delaware
  • +6 more
Aug 12, 2021

Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin's Lymphoma Trial in Wuhan (Fludarabine + Cyclophosphamide

Recruiting
  • Acute Lymphocytic Leukemia
  • +2 more
  • Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells
  • Wuhan, Hubei, China
    Union Hospital, Huazhong University of Science and Technology
Apr 5, 2021

Non Hodgkin's Lymphoma Trial in Shijiazhuang (PEG-rhG-CSF)

Unknown status
  • Non Hodgkin's Lymphoma
  • Shijiazhuang, Hebei, China
    The fourth hospital of Hebei Medical University
Aug 2, 2020

Non Hodgkin's Lymphoma Trial (Fusilev, Folotyn)

Withdrawn
  • Non Hodgkin's Lymphoma
  • (no location specified)
Jan 21, 2020

Hodgkin Lymphoma, Lymphocytic Leukemia, Mixed Cell Leukemia Trial run by the NCI (Stem cell transplantation)

Completed
  • Hodgkin Lymphoma
  • +8 more
  • Stem cell transplantation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 13, 2019

Leukemia, Non Hodgkin's Lymphoma, Aplastic Anemia Trial in Houston (Megadose T-cell Depleted HLA-nonidentical Blood Progenitor

Terminated
  • Leukemia
  • +2 more
  • Megadose T-cell Depleted HLA-nonidentical Blood Progenitor Cell Transplantation
  • Houston, Texas
    MD Anderson Cancer Center
Oct 29, 2018

Hodgkin's Lymphoma, Leukemia, Myelodysplastic Syndrome(MDS) Trial in Baltimore (drug, radiation, biological)

Completed
  • Hodgkin's Lymphoma
  • +4 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Oct 12, 2018

Chronic Lymphocytic Leukemia, GVHD, Hodgkin's Disease Trial run by the NCI (Th2 cells in allo HSCTT, Th2 Cells)

Completed
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Th2 cells in allo HSCTT
  • Th2 Cells
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 3, 2018

Non Hodgkin's Lymphoma, Hodgkin Disease, Multiple Myeloma Trial in Boston (Fludarabine and total body irradiation, Total body

Terminated
  • Non Hodgkin's Lymphoma
  • +2 more
  • Fludarabine and total body irradiation
  • Total body irradiation
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 26, 2018

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia Trial in Singapore (infusion of allogeneic CIK

Completed
  • Acute Myeloid Leukemia
  • +6 more
  • infusion of allogeneic CIK cells
  • Singapore, Singapore
    Singapore General Hospital
Feb 9, 2017

Hodgkin's Disease, Non Hodgkin's Lymphoma, Myeloma Trial in Durham

Completed
  • Hodgkin's Disease
  • +4 more
    • Durham, North Carolina
      Duke University Health System
    May 3, 2016

    Tumors, Non Hodgkin's Lymphoma Trial in Baltimore, Toronto, Greenfield Park (MGCD0103)

    Completed
    • Tumors
    • Non Hodgkin's Lymphoma
    • Baltimore, Maryland
    • +2 more
    Jan 6, 2015

    Non Hodgkin's Lymphoma Trial in Indianapolis (clofarabine)

    Completed
    • Non Hodgkin's Lymphoma
    • Indianapolis, Indiana
      Indiana University Cancer Center
    Sep 10, 2014

    Hodgkin's Disease, Non Hodgkin's Lymphoma, Myeloma Trial in Durham (Non-myeloablative Stem Cell Transplantation)

    Completed
    • Hodgkin's Disease
    • +4 more
    • Non-myeloablative Stem Cell Transplantation
    • Durham, North Carolina
      Duke University Health System
    May 2, 2014

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia Trial in Erlangen (allogeneic donor derived

    Unknown status
    • Acute Myeloid Leukemia
    • +7 more
    • allogeneic donor derived B-lymphocytes
    • Erlangen, Germany
      Medical Department 5, University Hospital Erlangen
    Mar 24, 2014

    Lymphoma, Non Hodgkin's Lymphoma, Hodgkin's Disease Trial in Germany (Plerixafor (AMD3100), Can be any registered nonpegylated

    Completed
    • Lymphoma
    • +3 more
    • Plerixafor (AMD3100)
    • Can be any registered nonpegylated form of G-CSF
    • Berlin, Germany
    • +4 more
    Feb 10, 2014

    Non Hodgkin's Lymphoma, Hepatitis B Trial in Taipei (Entecavir prophylaxis, Therapeutic entecavir)

    Completed
    • Non Hodgkin's Lymphoma
    • Hepatitis B
    • Entecavir prophylaxis
    • Therapeutic entecavir
    • Taipei, Taiwan
      Taipei Veterans General Hospital-Division of Gastroenterology, D
    May 27, 2013

    Hodgkin's Lymphoma, Non Hodgkin's Lymphoma Trial in Toronto (PET Scan)

    Completed
    • Hodgkin's Lymphoma
    • Non Hodgkin's Lymphoma
    • PET Scan
    • Toronto, Ontario, Canada
      University Health Network, Princess Margaret Hospital
    Dec 17, 2012

    Chronic Myelogenous Leukemia, Multiple Myeloma, Non Hodgkin's Lymphoma Trial in Houston (CD8 Depleted Donor Lymphocyte)

    Terminated
    • Chronic Myelogenous Leukemia
    • +4 more
    • CD8 Depleted Donor Lymphocyte
    • Houston, Texas
      UT MD Anderson Cancer Center
    Aug 22, 2012

    Lymphoma, Non Hodgkin's Lymphoma Trial in San Juan (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone)

    Completed
    • Lymphoma
    • Non Hodgkin's Lymphoma
    • Cyclophosphamide, Doxorubicin, Vincristine and Prednisone
    • San Juan, Puerto Rico
      Hospital Auxilio Mutuo Cancer Center
    Feb 3, 2012

    Non Hodgkin's Lymphoma Trial in Busan, Seoul, Ulsan (Busulfan, Etoposide, Cytarabine, Melphalan)

    Unknown status
    • Non Hodgkin's Lymphoma
    • Busulfan, Etoposide, Cytarabine, Melphalan
    • Busan, Korea, Republic of
    • +4 more
    Dec 1, 2010

    Chemo-Induced Nausea and Vomiting, Non Hodgkin's Lymphoma Trial in Modena (Palonosetron)

    Completed
    • Chemotherapy-Induced Nausea and Vomiting
    • Non Hodgkin's Lymphoma
    • Modena, Italy
      Gruppo Italiano Studio Linfomi
    Nov 24, 2009